| No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
| 1 |
rs550575847 |
chr13:65638017-65638018 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 2 |
rs201048632 |
chr13:65638022-65638023 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 3 |
rs58784087 |
chr13:65638023-65638024 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 4 |
rs80317155 |
chr13:65638024-65638025 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 5 |
rs149066642 |
chr13:65638046-65638047 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 6 |
rs539087093 |
chr13:65638110-65638111 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 7 |
rs559101644 |
chr13:65638120-65638121 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 8 |
rs112431895 |
chr13:65638207-65638208 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 9 |
rs200483258 |
chr13:65638208-65638209 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 10 |
rs201564446 |
chr13:65638209-65638210 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 11 |
rs201960350 |
chr13:65638210-65638211 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 12 |
rs575108168 |
chr13:65638271-65638272 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 13 |
rs542204238 |
chr13:65638274-65638275 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 14 |
rs372713810 |
chr13:65638303-65638304 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 15 |
rs528087569 |
chr13:65638326-65638327 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 16 |
rs142106172 |
chr13:65638358-65638359 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 17 |
rs559531951 |
chr13:65638377-65638378 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 18 |
rs73504687 |
chr13:65638392-65638393 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 19 |
rs369069131 |
chr13:65638419-65638420 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 20 |
rs550786367 |
chr13:65638476-65638477 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 21 |
rs76123968 |
chr13:65638535-65638536 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 22 |
rs201836283 |
chr13:65638565-65638566 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 23 |
rs530064323 |
chr13:65638567-65638568 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 24 |
rs546921527 |
chr13:65638593-65638594 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 25 |
rs566830384 |
chr13:65638638-65638639 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 26 |
rs200446088 |
chr13:65638657-65638658 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 27 |
rs567034779 |
chr13:65638730-65638731 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 28 |
rs539049743 |
chr13:65638774-65638775 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 29 |
rs151160061 |
chr13:65638816-65638817 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 30 |
rs375909716 |
chr13:65638841-65638842 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 31 |
rs531500963 |
chr13:65638861-65638862 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 32 |
rs181821961 |
chr13:65638864-65638865 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 33 |
rs534785937 |
chr13:65638865-65638866 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 34 |
rs185218803 |
chr13:65638914-65638915 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 35 |
rs555183070 |
chr13:65639073-65639074 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 36 |
rs575026804 |
chr13:65639157-65639158 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 37 |
rs386468804 |
chr13:65639166-65639167 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 38 |
rs539813485 |
chr13:65639169-65639170 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 39 |
rs374891939 |
chr13:65639227-65639228 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 40 |
rs75623529 |
chr13:65639242-65639243 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 41 |
rs572480688 |
chr13:65639245-65639246 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 42 |
rs75015798 |
chr13:65639258-65639259 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 43 |
rs145190290 |
chr13:65639274-65639275 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 44 |
rs564817787 |
chr13:65639277-65639278 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 45 |
rs575339222 |
chr13:65639286-65639287 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 46 |
rs544073646 |
chr13:65639288-65639289 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 47 |
rs552894747 |
chr13:65639314-65639315 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 48 |
rs201144357 |
chr13:65639356-65639357 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 49 |
rs4372585 |
chr13:65639357-65639358 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 50 |
rs546880630 |
chr13:65639383-65639384 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
Variant related diseases (count:93)
